Are carcinogens electron acceptors? A novel hypothesis.

Carcinogeneses Electron acceptors Epigenetic pathway Hypotheses Metabolic stress

Journal

Medical hypotheses
ISSN: 1532-2777
Titre abrégé: Med Hypotheses
Pays: United States
ID NLM: 7505668

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 18 07 2020
revised: 27 07 2020
accepted: 28 08 2020
pubmed: 18 11 2020
medline: 15 5 2021
entrez: 17 11 2020
Statut: ppublish

Résumé

Carcinogens play a key role in cancer initiation. Conventional theories support the concept of genetic changes inducing tumorigenesis through proteomics and metabolomics which lead to cancer development. Current research provides evidence that metabolic genes may be altered long before mutation of tumour suppressor genes, strongly suggesting that metabolic changes may be preceding the changes seen at a genetic level. Since cancer has long been known to occur through gene regulation, an impaired cellular respiration without utilizing mitochondrial function has been an area of active interest. We hypothesize the activity of carcinogens as electron acceptors to disrupt the normal glycolysis cycle happening in a cell by acting as positive ligands. The continuous restoration of NAD+ to cytosol by oxidation of NADH with carcinogen as electron acceptor creates a metabolic pathway to assist in the carcinogenic process. This metabolic pathway continues through an adaptive process, supplemented by pyruvate converting to lactate providing a constant pool of NAD+ to continue the glycolytic pathway. We also hypothesize that carcinogenesis occurs as a precursor to metabolic stress which may promote altered genetic and protein expression causing aberrant epigenetic and cell signaling pathways.

Identifiants

pubmed: 33201802
pii: S0306-9877(20)32293-3
doi: 10.1016/j.mehy.2020.110235
pii:
doi:

Substances chimiques

Carcinogens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110235

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

U S Vishal Rao (US)

Dept of Head and Neck Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India.

Gururaj Arakeri (G)

Dept of Head and Neck Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India; Department of Oral and Maxillofacial Surgery, Navodaya Dental College and Hospital, Raichur, Karnataka, India. Electronic address: gururaj.arakeri@gmail.com.

Anand Subash (A)

Dept of Head and Neck Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India.

M Venkatesh (M)

Dept of Head and Neck Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India.

Peter A Brennan (PA)

Department of Oral & Maxillofacial Surgery, Queen Alexandra Hospital, Portsmouth, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH